HighTower Advisors’s ImmuCell ICCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$245K Hold
24,354
﹤0.01% 3383
2026
Q1
$154K Buy
24,354
+5,000
+26% +$32K ﹤0.01% 3555
2025
Q4
$119K Sell
19,354
-2,000
-9% -$11.8K ﹤0.01% 3478
2025
Q3
$138K Hold
21,354
﹤0.01% 3476
2025
Q2
$149K Hold
21,354
﹤0.01% 3388
2025
Q1
$102K Hold
21,354
﹤0.01% 3352
2024
Q4
$110K Hold
21,354
﹤0.01% 3358
2024
Q3
$77K Hold
21,354
﹤0.01% 3354
2024
Q2
$103K Sell
21,354
-100
-0.5% -$481 ﹤0.01% 3201
2024
Q1
$115K Buy
21,454
+100
+0.5% +$515 ﹤0.01% 3122
2023
Q4
$108K Hold
21,354
﹤0.01% 3179
2023
Q3
$111K Hold
21,354
﹤0.01% 3073
2023
Q2
$109K Hold
21,354
﹤0.01% 3056
2023
Q1
$110K Hold
21,354
﹤0.01% 2920
2022
Q4
$131K Hold
21,354
﹤0.01% 2897
2022
Q3
$160K Buy
21,354
+3,000
+16% +$24.5K ﹤0.01% 2657
2022
Q2
$159K Hold
18,354
﹤0.01% 2682
2022
Q1
$177K Buy
18,354
+100
+0.5% +$863 ﹤0.01% 2871
2021
Q4
$146K Hold
18,254
﹤0.01% 2852
2021
Q3
$169K Buy
18,254
+2,500
+16% +$23.7K ﹤0.01% 2754
2021
Q2
$150K Hold
15,754
﹤0.01% 2728
2021
Q1
$152K Sell
15,754
-1,120
-7% -$10.5K ﹤0.01% 2672
2020
Q4
$101K Buy
16,874
+3,500
+26% +$20.4K ﹤0.01% 2350
2020
Q3
$73K Hold
13,374
﹤0.01% 2273
2020
Q2
$62K Hold
13,374
﹤0.01% 2183
2020
Q1
$51K Sell
13,374
-1,600
-11% -$7.88K ﹤0.01% 2008
2019
Q4
$77K Buy
+14,974
New +$77.2K ﹤0.01% 2098

Other funds holding ICCC

HighTower Advisors's ICCC Position: Q2 2026 in Review

HighTower Advisors held its ImmuCell (ICCC) position steady in Q2 2026 at 24,354 shares worth $245K. The position accounts for ﹤0.01% of the portfolio, ranked #3383.

HighTower Advisors first reported a position in ICCC in Q4 2019 and has held it in 27 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • HighTower Advisors held 24,354 shares of ImmuCell worth $245K as of Q2 2026.
  • HighTower Advisors left its ImmuCell share count unchanged in Q2 2026.
  • ImmuCell made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #3383 holding.
  • HighTower Advisors first reported a position in ImmuCell in Q4 2019 and has held it in 27 quarters since.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.